Description: Presented at September 1994 Valuation Actuary Symposium. This session presents the approaches of a stock and a mutual company to surplus management, and the application of recent research in risk theory to surplus management.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: Presented at October 1986 Annual Meeting. This session discussion is about how capital should be measured, cash flow based surplus, what performance measures are reliable, return on equity, book gains, terminal funds, how much surplus is needed, business planning for future capital needs, capital restructuring, how should multiple risks be combined and qualitative issues versus numbers as they relate to future growth.

Description: This panel will discuss the current status of NAIC activities with respect to risk-based capital RBC. The potential impact on financial reporting with respect to health products, specifically, indemnity, HMO, disability, and nontraditional products will also be discussed. From the Record of the Society of Actuaries, Vol.21, No. 4a.

Description: Presented at May 2002 Spring Meeting. Attendees learn about the new capital allocation, the financial products company 'FPC' model recently developed by S&P -including S&P's view of interest rate risk and credit risk in the FPC model, challenges of implementing the model for a life insurance company, and how the FPC model compares to economic capital methodology.

Description: Presented at May 2002 Spring Meeting. This session covers NAIC 2001 changes to RBC requirements, the impact they have had on regulators, the rating agency reaction and proposed changes for 2002.

Description: Presented at September 1995 Valuation Actuary Symposium. Discusses the Health Organization Risk-Based Capital formula.

Description: Presented at May 2005 Spring Meeting. Panelists discuss annuity risk management, with particular focus on RBC and the proposed Actuarial Guideline on reserving, and how this can be applied to new product development as well as in-force product management.

Description: The International Association of Insurance Supervisors (IAIS) continues its development of the Insurance Capital Standard (ICS) with the introduction of ICS 1.0 in summer 2017 and plans for ICS 2.0 in 2019. This session will provide updates on the development of the standards and summarize insights from Field Testing and ICS Consultations. This session will deliver an overview of the framework and provide industry and regulatory perspectives on potential implications and next steps.

Description: Presented at September 1995 Valuation Actuary Symposium. Discusses surplus management, including RBC, the capital management process and techniques, allocations of capital, raising capital, and rating agencies.